
Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.
The Financial Analyst will support the Commercial and G&A finance business partners in finance activities such as month-end close and accruals, invoice generation and processing, data validation of budget and LE and administration of the company’s financial planning tool.
Shionogi, established in 1878, is dedicated to developing innovative treatments for global health challenges such as antimicrobial resistance and COVID-19. With a history of introducing novel antibiotics and advanced medications for HIV and influenza, the company continues to advance clinical programs in areas like Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Driven by a commitment to patient impact, Shionogi fosters strategic partnerships with industry leaders to accelerate scientific advancements and deliver first-in-class therapies worldwide.